It has also committed to further research and monitoring the drugs effects to reassure users and respond to emerging concerns
Trial design: 751 adults with obesity (BMI 30, or 27 with at least one comorbidity) No type 2 diabetes 72-week follow-up Tirzepatide 10mg or 15mg vs Semaglutide 2.4mg Results at 72 weeks: When looking at tirzepatide weight loss results from SURMOUNT-5 alongside semaglutide weight loss results from the STEP trials, the gap is consistent and statistically significant across every subgroup sex, age, baseline BMI, and presence of metabolic comorbidities

Ivim Health GLP-1 ID at a Glance (2026) Program Type: Telehealth GLP-1 weight management (virtual consultations + medication delivery) Medication: Primarily compounded semaglutide and compounded tirzepatide (not FDA-approved finished products) Published Study: 1,131 completers, 19.5% average body weight reduction at 52 weeks (retrospective, company-authored, no control group) Starting Cost: Approximately $75-$133/month medication + $74.99/month program fee (verify current pricing on official website) Cancellation Policy: No cancellation once program term begins (1, 2, 4, or 6 months) Prescription Required: Yes - clinical eligibility determined solely by a licensed clinician after medical evaluation Coverage: 49 U.S
In addition, Livarise Injection (3ml Cartridge +10 Needles) is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring